Central Retinal Vein Occlusion After Discontinuation of Rivaroxaban Therapy in a Young Patient with COVID-19 Pulmonary Embolism: A Case Report

Bernadetta Płatkowska-Adamska; Magdalena Kal; Joanna Krupińska; Michał Biskup; Dominik Odrobina

doi:10.12659/AJCR.937739

01 November 2022 : Case report Poland

Central Retinal Vein Occlusion After Discontinuation of Rivaroxaban Therapy in a Young Patient with COVID-19 Pulmonary Embolism: A Case Report

Unusual clinical course, Unusual or unexpected effect of treatment, Unexpected drug reaction

Bernadetta Płatkowska-Adamska^12ABDEF*, Magdalena Kal^12BDG, Joanna Krupińska^1BF, Michał Biskup^2ACD, Dominik Odrobina^123DE

DOI: 10.12659/AJCR.937739

Am J Case Rep 2022; 23:e937739

Authors information Article notes Copyright and License information

Background Case Report Discussion Conclusions References:

Related articles Order reprints Share article Share by email

View HTML version

Figure 1. (A) Color fundus photography of the right eye after the onset of symptoms. Visible tortuosity and dilatation of all branches of central retinal vein with dot, blot, and flame hemorrhages, numerous cotton-wool spots, mild disc, and macular edema. (B) Swept source optical coherence tomography of the right eye showing cystoid macular edema before intravitreal injection of ranibizumab.

Back to the Article

Central Retinal Vein Occlusion After Discontinuation of Rivaroxaban Therapy in a Young Patient with COVID-19 Pulmonary Embolism: A Case Report

Your Privacy